ng Aurelio Arias, Gim c t vn chin lc ca cng ty d liu y t Iqvia, nhn mnh vai tr trung tm ca chu trong giai on ti: Gn mt phn ba ngi trng thnh bo ph trn th gii sng ti cc quc gia ni semaglutide sp ht hn bo h
K.ThurmanJ
A Phase 2 clinical trial evaluating semaglutide, a related GLP-1 medication , showed robust reductions in alcohol consumption during laboratory-based self-administration tasks
Graphical Abstract Similar content being viewed by others Introduction Type 2 diabetes mellitus (T2DM) affects an estimated 462 million people worldwide and is strongly associated with cardiovascular disease (CVD), the leading cause of morbidity and mortality in this population [1,2,3]
Coverage is a significant issue and certainly does prevent quite a significant number of people who may benefit from these kinds of medications and are interested in taking that from being able to have access to the medication
You posted some pictures recently, and fans defended you by saying you werent on a GLP-1 drug